Sanofi's Becky Germino on communicating value, AI and the role of HEOR in supporting access & pricing leaders

Om avsnittet

In this episode we look at market access through a different lens. We're joined by Becky Germino who has extensive experience in HEOR across a broad range of pharma organisations.
Becky joined Sanofi this year as HEVA, Neurology and Immunology Team Leader and explains the key priorities for HEOR teams and their role in working closely with market access to help them define and communicate patient value.
The discussion also explores the role of AI for HEOR and market access teams and what's on the horizon that leaders should prepare for.

The opinions shared in this episode are Becky's own views.

Send us Fan Mail

Om avsnittet

Fler avsnitt

Understanding Payer Perceptions with Megan O'Brien

Pricing Under Pressure: What MFN Really Means for Global Strategy

Navigating Global Policy Shifts with Nikhil Taxak

Beyond the Headlines: Understanding MFN's True Impact on Market Access

Revolutionary Strategies in Orphan Drug Development with Isabel Rubio

Elevating launch excellence: The strategic value of early market access involvement with Lizzie Shanahan, Sanofi

Getting ready for the JCA: Why cross-functional collaboration matters with Silvy Mardiguian, BeiGene

The rise of multi-stakeholder capitalism in market access with Jie Shen, CSL

Authentic leadership in Market Access with Katrin Jack, Galderma

Market Access in emerging markets with Ezgi Erdogan, GSK